YALE UNIVERSITY – ASHLEY LOSIER, MD
Advancing multidisciplinary research and clinical innovation in bronchiectasis, NTM pulmonary disease, chronic airway infections, and translational pulmonary medicine.
Ashley Losier, MD
Principal Investigator
Yale University
Institution
Yale Center for Asthma and Airways Disease (YCAAD)
Research & Clinical Program
Project Overview
Yale University conducts multidisciplinary clinical and translational research focused on bronchiectasis, NTM pulmonary disease, chronic airway infections, and advanced airway disease to improve patient care and therapeutic innovation.
Project Summary
The Yale Center for Asthma and Airways Disease (YCAAD) supports a collaborative research environment focused on bronchiectasis, NTM pulmonary infections, COPD, and asthma. The program integrates clinical care, translational science, computational phenotyping, microbiology research, and multicenter clinical trials while providing strong mentorship and educational opportunities for trainees and early-stage investigators.
Project Goals
- Advance translational research in bronchiectasis and NTM pulmonary disease
- Investigate mechanisms of antibiotic tolerance and immune dysfunction
- Develop novel antimicrobial and therapeutic strategies
Impact
Yale’s multidisciplinary airway disease program advances understanding of chronic pulmonary infections, bronchiectasis, and NTM disease through translational science, clinical trials, and collaborative research initiatives. Ongoing studies contribute to improved diagnostics, therapeutic development, and patient-centered care strategies.
Advancing Research. Improving Lives.
Supporting innovative pulmonary research and multidisciplinary clinical care for patients with bronchiectasis, NTM infections, and chronic airway diseases.

ASHLEY LOSIER, MD
Email: ashley.losier@yale.edu
Project Overview
Yale University conducts multidisciplinary research focused on bronchiectasis, NTM pulmonary disease, and chronic airway infections to advance pulmonary care and translational medicine.